Video Series: Our Team
Health Topics: Genetics
Dr. Summar discussing genetics department (1 of 3)
"We love going to Children's National. The first visit was very hard since we found out about the diagnosis, but after that we have only had good visits. My daughter loves going there."
Read More of Ashley's Story
Invest in future cures for some of life's most devastating diseases
Keep in touch with Children's National by signing up for our newsletters.
Pediatric Specialists of Virginia begins operations as a collaboration between Children's National and Inova.
Marshall Summar, MD, talks to other genetics specialists about the impact of genetics on the field of cardiology.
Kenneth Rosenbaum, MD, speaks with Parents.com about Down syndrome.
A novel anti-inflammatory in development for the chronic treatment of Duchenne muscular dystrophy by ReveraGen BioPharma, a private spin-off company from Children’s National Health System, has received $2 million from four nonprofit organizations.